Phase II study of alemtuzumab in combination with pentostatin in patients with T-cell neoplasms.
Ravandi F, Aribi A, O'Brien S, Faderl S, Jones D, Ferrajoli A, Huang X, York S, Pierce S, Wierda W, Kontoyiannis D, Verstovsek S, Pro B, Fayad L, Keating M, Kantarjian H.
Ravandi F, et al. Among authors: fayad l.
J Clin Oncol. 2009 Nov 10;27(32):5425-30. doi: 10.1200/JCO.2009.22.6688. Epub 2009 Oct 5.
J Clin Oncol. 2009.
PMID: 19805674
Free PMC article.
Clinical Trial.